Successful Treatment of BRAF V600R ‐Mutant Melanoma of Unknown Primary Identified by Liquid Biopsy With BRAF / MEK Inhibitors
- 27 November 2025
- journal article
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2)
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Advancements and Challenges in Personalized Therapy for BRAF-Mutant Melanoma: A Comprehensive ReviewJournal of Clinical Medicine, 2024
- A Japanese case of melanoma of unknown origin with a rare BRAFV600R mutation was successfully treated with BRAF/MEK inhibitorsDrug Discoveries & Therapeutics, 2022
- Circulating tumor DNA: current challenges for clinical utilityJournal of Clinical Investigation, 2022
- BRAF Gene and Melanoma: Back to the FutureInternational Journal of Molecular Sciences, 2021
- The clinical characteristics of melanoma with BRAF V600R mutation: a case series studyMelanoma Research, 2020